Neumora TherapeuticsNMRA
那斯達克 · USD
2.25
+0.03
(+1.35%)
收盤 04/29 03:59 (UTC+8)
04/29 03:59 (UTC+8)
Neumora TherapeuticsNMRA
2.25
+0.03
(+1.35%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 58,480 | 57,700 | 54,040 | - | - | - | - | 60,074 | 114,004 | 56,864 |
研發費用 | 44,670 | 40,520 | 38,724 | 52,151 | 45,912 | 60,630 | 48,628 | 45,757 | 38,864 | 41,601 |
推銷及管理費用 | 13,810 | 12,180 | 15,316 | 18,785 | 17,010 | 16,016 | 15,194 | 14,317 | 11,236 | 15,263 |
非經常性項目費用 | - | 5,000 | - | - | - | - | - | - | 63,904 | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -58,480 | -57,700 | -54,040 | -70,936 | -62,922 | -76,646 | -63,822 | -60,074 | -114,004 | -56,864 |
其他收入及費用 | 1,066 | 2,128 | 1,334 | 3,049 | 4,103 | 4,152 | 5,247 | 6,353 | 5,542 | 3,837 |
利息費用 | 2,036 | 1,183 | - | - | - | - | - | - | - | - |
稅前純益 | -59,450 | -56,755 | -52,706 | -67,887 | -58,819 | -72,494 | -58,575 | -53,721 | -108,462 | -53,027 |
所得稅 | - | - | 25 | 105 | - | 53 | 125 | - | 268 | - |
稅後純益 | -59,450 | -56,755 | -52,731 | -67,992 | -58,819 | -72,547 | -58,700 | -53,721 | -108,730 | -53,027 |
基本每股稅後盈餘(元) | -0.35 | -0.35 | -0.33 | -0.42 | -0.37 | -0.45 | -0.37 | -0.34 | - | -1.14 |
稀釋每股稅後盈餘(元) | -0.35 | -0.35 | -0.33 | -0.42 | -0.37 | -0.45 | -0.37 | -0.34 | -0.04 | -1.09 |
基本平均股數(千股) | 168518.00 | 161838.00 | 161691.00 | 161451.00 | 160984.00 | 159576.00 | 158984.00 | 157943.00 | - | 46691.00 |
稀釋平均股數(千股) | 168518.00 | 161838.00 | 161691.00 | 161451.00 | 160984.00 | 159576.00 | 158984.00 | 157943.00 | - | 46691.00 |
還原基本每股稅後盈餘(元) | -0.35 | -0.35 | -0.33 | -0.42 | -0.37 | -0.45 | -0.37 | -0.34 | - | -1.14 |
還原稀釋每股稅後盈餘(元) | -0.35 | -0.35 | -0.33 | -0.42 | -0.37 | -0.45 | -0.37 | -0.34 | -0.04 | -1.09 |
還原基本平均股數(千股) | 168,518 | 161,838 | 161,691 | 161,451 | 160,984 | 159,576 | 158,984 | 157,943 | - | 46,691 |
還原稀釋平均股數(千股) | 168,518 | 161,838 | 161,691 | 161,451 | 160,984 | 159,576 | 158,984 | 157,943 | - | 46,691 |
EBITDA(千元) | -56,333 | -56,161 | -53,583 | -69,019 | -59,743 | -73,664 | -60,580 | -54,710 | -108,969 | -53,890 |